World Psoriasis Day 2024: New Treatments and Research Trends
XTalks
OCTOBER 24, 2024
Trends in Psoriasis Research: Biologics, Biosimilars and New Therapies Recent innovations in biologics and biosimilars have transformed psoriasis care.
Delgocitinib Investigational Cream Outshines Standard Care in Chronic Hand Eczema Trial
XTalks
APRIL 25, 2025
It also improved health-related quality of life, as measured by the Dermatology Life Quality Index (DLQI). Dr. Charles Lynde, chief medical director at The Lynde Institute for Dermatology and Associate Professor at the University of Toronto, emphasized the significance of the findings: We know that CHE is an under-researched condition.
Trials 
52
52 Join 21,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
DermTech Presents New Clinical Research Abstract at the 2020 Fall Clinical Dermatology Conference
BioTech 365
NOVEMBER 17, 2020
DermTech Presents New Clinical Research Abstract at the 2020 Fall Clinical Dermatology Conference DermTech Presents New Clinical Research Abstract at the 2020 Fall Clinical Dermatology Conference LA JOLLA, Calif.–(BUSINESS –(BUSINESS WIRE)–DermTech, Inc.
Dermatology 40
40 
Internship Program Boosts Clinical Research Workforce Development in Pennsylvania
ACRP blog
OCTOBER 3, 2023
Lessons learned from a new clinical research internship program held in central Pennsylvania last summer have helped prepare new and upcoming entrants for the research workforce, as well as to inform how the next generation of the program will evolve. alongside the Milton S. alongside the Milton S.
Animated and Live Action Content Delivers Precise Training for Dermatology Studies
WCG Clinical
MARCH 30, 2023
Uniform Live Action Training Using InvestigatorSpace Speeds Up Study Start Times In one case, a global pharmaceutical company used WCG’s training solutions to support two dermatology studies they were running.
Dermatology 52
52 
Incannex engages QPS for CannQuit and ReneCann
Pharmaceutical Technology
APRIL 17, 2023
The company will help in managing the clinical trials of the products once the regulators provide approvals for the proposed research and development programmes. In 2022, the company acquired CannQuit and ReneCann products as part of the acquisition of APIRx Pharmaceuticals.
Dermatology 130
130 
Clinical Research during Recession: How Unified eClinical solutions are helpful?
Cloudbyz
AUGUST 7, 2024
In general, the total number of initiated clinical trials dropped by about 25% , where the reduction in the research applied in the fields of dermatology and lifestyle amounted to about 20%. first appeared on CLOUDBYZ.
Breaking News: German CRO Opens Office In North Carolina
ECRG Media's Clinical Research Podcast
SEPTEMBER 11, 2018
A german CRO that specializes in Dermatology clinical trials has decided to open an office in North Carolina. Not in the Biotech and clinical research hub of the Raleigh/Durham Triangle but in the coast near Wilmington. Have you heard about ProInnovera before or have an interest in Dermatology?
Dermatology 52
52 
Breaking News: German CRO Opens Office In North Carolina
ECRG Media's Clinical Research Podcast
SEPTEMBER 11, 2018
A german CRO that specializes in Dermatology clinical trials has decided to open an office in North Carolina. Not in the Biotech and clinical research hub of the Raleigh/Durham Triangle but in the coast near Wilmington. Have you heard about ProInnovera before or have an interest in Dermatology?
Dermatology 52
52 
Regulator and Funder? FDA’s Orphan Products Grants Program awards significant funding to help move promising treatments through clinical development
FDA Law Blog
NOVEMBER 10, 2024
FY2024 Awardees & Observations For the FY2024 Orphan Products Clinical Trials Grants Program, FDA received 51 grant applications and awarded only seven new clinical trials a grant, providing more than $17.2 million to clinical researchers over the next four years to advance the development of medical products for rare diseases.
Production 69
69 
STAT+: Pharmalittle: Private equity moving to buy clinical trials firms; data provider limits media access to drug prices
STAT News
DECEMBER 2, 2022
And a fragmented clinical trials industry has made it a prime target for private equity, which often consolidates markets by merging companies. To date, 11 of the 25 private equity firms identified by industry tracker PitchBook as the top investors in health care have bought stakes in clinical research companies. But be safe.
A Closer Look At Hidradenitis Suppurativa: Disease, Causes, & Treatment
Olympian Clinical Research
AUGUST 5, 2020
Although severe cases of HS can appear unsightly, with intense bruising or discoloration, pus, and boils; the condition is merely a type of dermatological condition the same as acne, psoriasis, and countless other skin conditions. . HS is not caused by lack of hygiene. However, that doesn’t mean that there is no hope!
Ensuring successful digital outreach and retention in atopic dermatitis trials
pharmaphorum
JULY 5, 2022
With more than 500 dermatology clinical trials currently underway, it is often heard that there is a ‘’competition for participants’’. Trial organisers face intense competition to find and recruit eligible patients for atopic dermatitis studies. Patient recruitment for moderate or severe atopic dermatitis.
Trials 118
118 
(Lopinavir + ritonavir) by Douglas Pharmaceuticals for Genital Warts (Condylomata Acuminata): Likelihood of Approval
Pharmaceutical Technology
FEBRUARY 24, 2023
Douglas provides products in various therapeutic areas which include psoriasis, eczema, dermatitis, chicken pox, constipation, laxative, neonatal, hormone regulation, dermatology, cardiovascular and measles, among others. Douglas collaborates with scientific researchers and external medical experts to advance clinical research.
(Lopinavir + ritonavir) by Douglas Pharmaceuticals for Cervical Intraepithelial Neoplasia (CIN): Likelihood of Approval
Pharmaceutical Technology
FEBRUARY 24, 2023
Douglas provides products in various therapeutic areas which include psoriasis, eczema, dermatitis, chicken pox, constipation, laxative, neonatal, hormone regulation, dermatology, cardiovascular and measles, among others. Douglas collaborates with scientific researchers and external medical experts to advance clinical research.
Orismilast Closer to Phase III as a Promising Oral Treatment for Atopic Dermatitis
XTalks
SEPTEMBER 30, 2024
Presented at the European Academy of Dermatology and Venereology (EADV) Congress 2024, the study highlighted significant improvements in key disease markers, positioning orismilast as a potential breakthrough in atopic dermatitis management.
Bristol Myers Squibb Data at the EADV 30th Anniversary Congress Highlight the Growing Body of Evidence on Deucravacitinib and Scientific Advancements for Patients with Serious Dermatologic Diseases
The Pharma Data
OCTOBER 1, 2021
The research, which spans clinical, health economics and outcomes research, translational, clinical pharmacology and preclinical presentations, highlights the breadth and depth of the company’s data on deucravacitinib, a first-in-class, oral, selective tyrosine kinase 2 (TYK2) inhibitor, also because the emerging dermatology pipeline.
Dermatology 52
52 
Grand Rounds June 28, 2024: Using ChatGPT to Facilitate Truly Informed Medical Consent (Fatima N. Mirza, MD, MPH)
Rethinking Clinical Trials
SEPTEMBER 24, 2024
Mirza, MD, MPH Chief Resident Department of Dermatology Warren Alpert Medical School of Brown University Slides Keywords Artificial Intelligence; ChatGPT; Informed Consent Key Points Artificial Intelligence (AI), when implemented thoughtfully in clinical settings, can lead to meaningful results for patients.
Clinical Trials 100
100 
Top Rosacea Treatments: Expert Recommendations
Olympian Clinical Research
MARCH 6, 2024
At Academic Alliance in Dermatology , we combine advanced technology, medication, and tailored skincare routines to effectively manage rosacea symptoms. Techniques like Intense Pulsed Light ( IPL ) therapy and Broad Band Light ( BBL ) therapy are both effective options offered at Academic Alliance in Dermatology.
Dermatology 52
52 
Leqselvi Can Achieve Nearly 90% Scalp Hair Coverage in Severe Alopecia Areata Patients
XTalks
JULY 31, 2024
“An oral JAK that delivers proven results will be impactful for the alopecia areata community,” added Dr. Natasha Mesinkovska, associate professor and vice chair for Clinical Research of Dermatology, University of California, Irvine and investigator in the Leqselvi clinical development program.
Immune Response 105
105 
The Transformative Benefits of Microneedling with PRP
Olympian Clinical Research
MAY 20, 2024
At Academic Alliance in Dermatology , we believe in providing treatments that enhance natural beauty. At Academic Alliance in Dermatology , we’re dedicated to helping you achieve the glowing, youthful skin you desire. The post The Transformative Benefits of Microneedling with PRP appeared first on Academic Alliance In Dermatology.
Dermatology 52
52 
Medical Grade vs. Drugstore Skincare Products: What’s the Difference?
Olympian Clinical Research
FEBRUARY 13, 2024
At Academic Alliance in Dermatology, we understand the importance of using products that not only care for your skin on the surface but also work effectively at a cellular level. Whether it’s aging , acne , or hyperpigmentation, these products are formulated based on clinical research and are proven to deliver results.
Production 52
52 
How Long Do Fillers Last?
Olympian Clinical Research
MAY 7, 2024
A common question we hear at Academic Alliance in Dermatology is: “How long do fillers last?” Enhance Your Natural Beauty at Academic Alliance in Dermatology Curious about fillers and how long they last? Academic Alliance in Dermatology is here to guide you. appeared first on Academic Alliance In Dermatology.
Filler 52
52 
How to Remove Age Spots: A Comprehensive Guide
Olympian Clinical Research
MARCH 1, 2024
If you are wondering how to remove age spots, Academic Alliance in Dermatology can help. Ways to Remove Age Spots At Academic Alliance in Dermatology, we specialize in advanced, professional treatments to effectively reduce age spots, ensuring our patients receive the highest standard of care. What are Age Spots?
Dermatology 52
52 
Your Guide to Skin Cancer Symptoms, Prevention and Treatment Options
Olympian Clinical Research
APRIL 17, 2024
At Academic Alliance in Dermatology , we understand that while enjoying the beautiful weather is one of the perks of living here, it comes with the responsibility of taking care of our skin. At Academic Alliance in Dermatology, we take this further to include the ABCDEFGHIs of melanoma. Protect your skin and your health.
Dermatology 52
52 Dermatology 52
52 
DiME digital measure is nocturnal scratch for atopic dermatitis
pharmaphorum
SEPTEMBER 8, 2022
Furthering DiME’s previous work on digital clinical measures, nocturnal scratch’s more widespread implementation aims to establish a firmer digital groundwork for future clinical research, technology development, and reimbursement decisions in the dermatological field, and thereby improve the lives of AD patients and caregivers.
Dermatology 52
52 
What is Hidradenitis Suppurativa: Signs, Causes and Treatments
Olympian Clinical Research
NOVEMBER 16, 2022
According to the American Academy of Dermatology , scientists believe that when a hair follicle becomes clogged with keratin, bacteria breed within it. Clinical Research on Hidradenitis Suppurativa. For these people, clinical research studies may be an option. Possible Causes of Hidradenitis Suppurativa.
SkinPen® Microneedling to Achieve Youthful-looking Skin
Olympian Clinical Research
APRIL 9, 2024
At Academic Alliance in Dermatology , we are proud to offer microneedling with SkinPen ®. Choosing SkinPen microneedling means opting for a treatment that is not only effective but also trusted by the providers at Academic Alliance in Dermatology. Why Choose SkinPen?
Dermatology 52
52 
Sunscreen Myths Debunked: The Truth About Protecting Your Skin
Olympian Clinical Research
MARCH 20, 2024
At Academic Alliance in Dermatology , we are committed to empowering our patients with accurate information, enabling them to make informed decisions about their skin health. The American Academy of Dermatology recommends reapplying sunscreen every two hours and even more frequently if you’re in water or sweating heavily.
Dermatology 52
52 
Povorcitinib Phase III Results Stir Mixed Signals for Incyte and Investors
XTalks
MARCH 18, 2025
Incytes recent announcement on the topline results from two Phase III clinical trials of povorcitinib in patients with hidradenitis suppurativa has stirred both hope and caution in the market.
Trials 59
59 
Understanding Atopic Dermatitis, Its Symptoms & Treatment
Olympian Clinical Research
JUNE 2, 2021
At OCR we’re committed to educating the public and raising awareness about diseases like eczema, so today we’re taking some time to walk you through everything you need to know about this common dermatology condition. For patients who don’t find relief from over the counter or prescription medications, clinical trials are a great solution!
Pediatric Psoriasis vs. Eczema
Olympian Clinical Research
AUGUST 19, 2022
In addition, clinical research may provide new information and breakthrough treatments. . The Benefits of Clinical Research for Pediatric Dermatology Conditions. Although there is currently no cure for either psoriasis or eczema, clinical research is constantly working to develop new and improved treatments.
Shielding Your Skin: How to Prevent Skin Cancer
Olympian Clinical Research
JANUARY 16, 2024
Prevent and Treat Skin Cancer at Academic Alliance in Dermatology At Academic Alliance in Dermatology , we are dedicated to providing you with comprehensive care and the latest insights into skin health and skin cancer prevention. In addition, schedule yearly appointments with a dermatologist for professional skin checks.
Dermatology 52
52 
Researchers Calling Participants to Help Explore Skin Conditions!
Trialfacts
FEBRUARY 21, 2023
Our team collectively possesses 60+ years of research experience including analytical chemistry, diagnostic testing, data science, human subjects research, and clinical research. We specialize in bringing robust science to the dermatological and consumer skincare industry.
Research 52
52 
Researchers Calling Participants to Help Explore Skin Conditions!
Trialfacts
FEBRUARY 21, 2023
Our team collectively possesses 60+ years of research experience including analytical chemistry, diagnostic testing, data science, human subjects research, and clinical research. We specialize in bringing robust science to the dermatological and consumer skincare industry.
Research 52
52 
Digital tools driving innovative clinical trials
pharmaphorum
JULY 8, 2022
Thread is helping customers create and utilise digital endpoints in therapeutic areas like dermatology, respiratory, and CNS applications where the voice data capture is becoming important. It’s super innovative and requires our industry to build an endpoint into a process. About the interviewees.
Clinical Trials 100
100 
Next Generation Complement Therapeutics: Potential Life-Changing Therapies for Multiple Rare Disorders
Roots Analysis
MARCH 3, 2022
Majority of these are biologics and are being developed for the treatment of different disease conditions, including dermatological, genetic, hematological and vascular, immunological and inflammatory, infectious, neurological, ophthalmic, renal disorders. Broad Clinical Trial Landscape. Next Generation Complement Therapeutics.
Rebuilding Clinical Trials in the Image of Patient Need: Key Takeaways from Reuters Pharma Clinical 2021
Pharma Marketing Network
APRIL 30, 2021
At this year’s Reuters Pharma Clinical 2021, I joined over 500 global leaders in clinical research as they discussed many of these issues under the theme, “rebuild clinical trials in the image of patient need.”. How do we increase the diversity of clinical trials?
Nemolizumab Delivers Significant Itch-Relief in Phase III Clinical Trials
XTalks
AUGUST 2, 2024
Phase III ARCADIA 1 and 2 results evaluating the safety and efficacy of nemolizumab in treating atopic dermatitis have been published in The Lancet.
BioSpace Movers & Shakers, Dec. 18
The Pharma Data
DECEMBER 17, 2020
Martin Carter Professor in Clinical Investigation and Head of the Laboratory of Investigative Dermatology at The Rockefeller University and Weinblatt is the co-director of Clinical Rheumatology at the Brigham and Women’s Hospital.
Development 52
52 
Acclaimed Makeup Artist Allan Avendaño Opens Up About Personal Skin Condition: Provides INSIDE LOOK At Life With Plaque Psoriasis
The Pharma Data
JUNE 28, 2021
. “Plaque psoriasis is a chronic autoimmune disease in which the immune system overproduces inflammatory proteins which results in red, scaly and thickened areas of skin,” said Dr. Jennifer Soung, dermatologist and Director of Clinical Research at Southern California Dermatology in Santa Ana, California.
Build a More Participant-Focused Trial: Amplify the Patient Voice in Clinical Research Technology Development
WCG Clinical
MAY 15, 2023
Study eDiaries are an example of a clinical research technology that can create additional burdens. As researchers, we must ask for patient feedback to better understand the ease of use of such patient technologies. Researchers must seek insights from the people who are the end users of these tools. It doesn’t.
PI Focus: Building Relationships Through Clinical Trials in the United Kingdom
Velocity Clinical Research
JULY 18, 2023
Born and trained in Egypt, he moved to the UK several years ago after working as a general practitioner there and deciding he loved the country and the clinical trial opportunities it offered. To join a clinical trial at Velocity, visit velocityclinicaltrials.com.
10 Trends and Statistics for Clinical Trials in 2023
XTalks
MAY 19, 2023
It is clear that the clinical research landscape continues to expand at a substantial rate. Growing Complexity of Clinical Trials Research teams are increasingly dealing with complex clinical trial designs and clinical research complexity.
Let's personalize your content